PRFX Kapitalisasi Akuntansi PainReform

Logo perusahaan publik PainReform (PRFX)

PainReform Ltd. (PRFX) specializes in developing innovative solutions for long-term postoperative pain management, utilizing technology that optimizes clinic service costs by accelerating patient recovery. Business growth is driven by the completion of final PRF-110 trials and pending FDA approval. The current metric stands at 0.00. The quotes provided below on GURU.Markets complement data regarding a stable expert staff and low employee turnover.

PRFX Kapitalisasi Buku PainReform Corp (04.07.2022 - 27.10.2026)

Rincian metrik lan analitis perusahaan PainReform (PRFX)

- rega lan prakiraan konsensus rega:
Bagan kutipan PainReform Corp|PRFX - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar PainReform Ltd|PRFX - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham PainReform|PRFX - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku painreform.com|PRFX - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal PainReform Ltd.|PRFX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal PainReform Ltd|PRFX - Utang perusahaan|Utang marang nilai buku PainReform Ltd
Pambiji fundamental:PRFX - PainReform Corp
Barang unggulan PainReform Ltd

Book value, represented by the current carrying amount of equity, measures the residual value of net assets after all liabilities are settled, establishing the fundamental safety threshold for investments. For PainReform Ltd. (PRFX), this indicator serves as a defensive buffer during the completion of PRF-110 clinical trials, allowing for an assessment of the business's actual material stability prior to receiving regulatory approvals and a potential revision of market value.

Analisis pesaing PainReform Ltd.

Haleon Corp (HLN) - Nilai Aset Bersih|Aset Bersih Perusahaan Kenvue Inc.|VRNA (veronapharma.com) - Kapitalisasi Akuntansi|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|liquidia.com - Kapitalisasi Buku|Nilai Buku Perusahaan Galapagos (GLPG)|ANIP: Nilai Akuntansi Perusahaan|MNKD (MannKind Corp.) - Nilai Buku Perusahaan|Amphastar Corp (AMPH) - Aset Bersih Perusahaan|PCRX (Pacira BioSciences) - Kapitalisasi Buku|Kapitalisasi Buku ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan AQST (Aquestive Therapeutics Inc)|SCPH: Nilai Buku Perusahaan|TECX - Ekuitas Perusahaan|Aset Bersih Perusahaan Tonix Pharmaceuticals TNXP|SXTC - Total Aset Bersih|Kapitalisasi Buku eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku EXOZ (Invizyne Technologies, Inc.)|Ekuitas Perusahaan ORMP|Entera Bio Ltd. (ENTX) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan HYFT (ipatherapeutics.com)|ABVC BioPharma, Inc. (ABVC) - Nilai Buku Perusahaan|Nilai Aset Bersih Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Kapitalisasi Buku|FGEN - Kapitalisasi Buku|Telomir Pharmaceuticals - Kapitalisasi Buku|RANI (Rani Therapeutics Holdings, Inc.) - Pambiji Buku Bisnis|Nilai Buku Perusahaan Synergy CHC Corp. (SNYR)|Kapitalisasi Akuntansi RLYB|Lexaria Bioscience (LEXX) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan Pulmatrix Corporation (PULM)|PTHL: Kapitalisasi Buku|Ekuitas Perusahaan Aptorum Group Ltd APM|Kapitalisasi Buku Lyra Therapeutics|IBO: Nilai Aset Bersih|Nilai Buku Perusahaan TNFA|YCBD (cbdMD) - Ekuitas Perusahaan|CYTO - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan LIPO|Nilai Buku Perusahaan OPTN (OptiNose)|Aset Bersih Perusahaan Pieris Pharmaceuticals Inc PIRS|Aset Bersih Perusahaan Procaps Group SA|Petros Pharma - Nilai Akuntansi Perusahaan|QLI - Nilai Buku Perusahaan|acelyrin.com (SLRN) - Nilai Buku Perusahaan|TFFP - Aset Bersih Perusahaan